Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Follows Eli Lilly's Footsteps To Sell Medicines Directly To Patients
Pfizer Inc (NYSE:PFE) is looking to build on the success of its COVID-19 vaccine rollout by introducing a direct-to-consumer medicines platform under the brand "Pfizer for All."
輝瑞公司（紐約證券交易所代碼：PFE）希望在其 COVID-19 疫苗推廣成功的基礎上再接再厲，推出一個以 “輝瑞爲所有人” 品牌的直接面向消費者的藥品平台。
The move, reflected in a recent trademark application, aims to provide medical information, mail-order pharmacy, and telehealth services to US patients.
此舉反映在最近的商標申請中，旨在向美國患者提供醫療信息、郵購藥房和遠程醫療服務。
Recent reports indicate Pfizer's intention to include various medications, including its COVID antiviral Paxlovid and diagnostic kits, on the platform later this year, expanding its offerings to cater to diverse healthcare needs.
最近的報告表明，輝瑞打算在今年晚些時候在該平台上加入各種藥物，包括其COVID抗病毒Paxlovid和診斷試劑盒，擴大其產品範圍以滿足不同的醫療需求。
Related: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With Discontinued Heartburn Drug Zantac.
相關： 輝瑞同意解決10,000多起與停產的胃灼熱藥物Zantac相關的癌症風險的訴訟。
The platform will offer a "downloadable mobile application for providing medical information" as well as "mail order pharmacy services" and "diagnostic test kits . . . for use in disease screening and detection", according to the trademark application, the FT writes.
英國《金融時報》寫道，根據商標申請，該平台將提供 “用於提供醫療信息的可下載移動應用程序” 以及 “郵購藥房服務” 和 “診斷檢測試劑盒。。用於疾病篩查和檢測”。
This initiative follows similar endeavors in the pharmaceutical industry to bypass traditional middlemen and directly reach consumers.
該舉措是在製藥行業採取類似舉措之後採取的，旨在繞過傳統的中間商，直接接觸消費者。
Earlier this year, Eli Lilly And Co (NYSE:LLY) launched its LillyDirect platform, marking an industry first.
今年早些時候，禮來公司（紐約證券交易所代碼：LLY）推出了其LillyDirect平台，這標誌着業界首創。
The "Pfizer for All" platform is positioned as a healthcare equity endeavor, seeking to simplify the often convoluted process through which US patients obtain their medications, the Financial Times highlights.
《金融時報》強調，“Pfizer for All” 平台被定位爲一項醫療保健股權項目，旨在簡化美國患者獲得藥物時經常錯綜複雜的過程。
Citing the sources familiar with the plans, the FT notes that Pfizer intends to leverage its brand equity gained from its pivotal role in combating the Covid-19 crisis.
英國《金融時報》援引熟悉計劃的消息人士的話指出，輝瑞打算利用其在應對Covid-19危機中的關鍵作用中獲得的品牌資產。
Despite Pfizer's favorable reception during the height of the vaccine rollout, its favorability score has experienced fluctuations. The company's stock value has also declined from its pandemic peak, facing skepticism from investors regarding its growth trajectory.
儘管輝瑞在疫苗推出的高峰期受到了好評，但其支持度得分卻出現了波動。由於投資者對其增長軌跡持懷疑態度，該公司的股票價值也已從疫情峯值下跌。
However, Timothy Mackey, a professor of global health at the University of California San Diego, believes that Pfizer's approach may resonate positively with consumers despite mixed sentiments surrounding pharmaceutical companies.
但是，加州大學聖地亞哥分校全球健康教授蒂莫西·麥基認爲，儘管圍繞製藥公司的情緒喜憂參半，但輝瑞的做法可能會引起消費者的積極共鳴。
Price Action: PFE shares are up 1.30% at $28.38 at last check Monday.
價格走勢：週一最後一次檢查時，PFE股價上漲1.30％，至28.38美元。
Photo via Shutterstock
照片來自 Shutterstock
譯文內容由第三人軟體翻譯。